Association of the selenoprotein 15-kDa (SEP15) polymorphisms with cancer risk: a meta-analysis

References

• Forsberg L, de Faire U, Morgenstern R. Oxidative stress, human genetic variation, and disease. Arch Biochem Biophys. 2001;389(1):84–93. doi: 10.1006/abbi.2001.2295
   PubMed Web of Science ®Google Scholar
• Zhuo P, Diamond AM. Molecular mechanisms by which selenoproteins affect cancer risk and progression. Biochim Biophys Acta. 2009;1790(11):1546–1554. doi: 10.1016/j.bbagen.2009.03.004
   PubMed Web of Science ®Google Scholar
• Davis CD, Tsuji PA, Milner JA. Selenoproteins and cancer prevention. Annu Rev Nutr. 2012;32(1):73–95. doi: 10.1146/annurev-nutr-071811-150740
   PubMed Web of Science ®Google Scholar
• Papp LV, Lu J, Holmgren A, Khanna KK. From selenium to selenoproteins: synthesis, identity, and their role in human health. Antioxid Redox Signal. 2007;9(7):775–806. doi: 10.1089/ars.2007.1528
   PubMed Web of Science ®Google Scholar
• Brown KM, Arthur JR. Selenium, selenoproteins and human health: a review. Public Health Nutr. 2001;4(2b):593–599.
   PubMedGoogle Scholar
• Labunskyy VM, Hatfield DL, Gladyshev VN. The Sep15 protein family: roles in disulfide bond formation and quality control in the endoplasmic reticulum. IUBMB Life. 2007;59(1):1–5. doi: 10.1080/15216540601126694
   PubMed Web of Science ®Google Scholar
• Gladyshev VN, Jeang KT, Wootton JC, Hatfield DL. A new human selenium-containing protein. Purification, characterization, and cDNA sequence. J Biol Chem. 1998;273(15):8910–8915.
   PubMed Web of Science ®Google Scholar
• Kryukov GV, Castellano S, Novoselov SV, Lobanov AV, Zehtab O. Characterization of mammalian selenoproteomes. Science. 2003;300(5624):1439–1443. doi: 10.1126/science.1083516
   PubMed Web of Science ®Google Scholar
• Kumaraswamy E, Malykh A, Korotkov KV, Kozyavkin S, Hu Y, Kwon SY, Moustafa ME, Carlson BA, Berry MJ, Lee BJ, et al. Structure-expression relationships of the 15-kDa selenoprotein gene. Possible role of the protein in cancer etiology. J Biol Chem. 2000;275(45):35540–35547. doi: 10.1074/jbc.M004014200
   PubMed Web of Science ®Google Scholar
• Hatfield DL, Yoo MH, Carlson BA, Gladyshev VN. Selenoproteins that function in cancer prevention and promotion. Biochim Biophys Acta. 2009;1790(11):1541–1545. doi: 10.1016/j.bbagen.2009.03.001
   PubMed Web of Science ®Google Scholar
• Peters U, Chatterjee N, Hayes RB, Schoen RE, Wang Y, Chanock SJ, Foster CB. Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. Cancer Epidemiol Biomarkers Prev. 2008;17(5):1144–1154. doi: 10.1158/1055-9965.EPI-07-2947
   PubMed Web of Science ®Google Scholar
• Vogt TM, Ziegler RG, Patterson BH, Graubard BI. Racial differences in serum selenium concentration: analysis of US population data from the Third National Health and Nutrition Examination Survey. Am J Epidemiol. 2007;166(3):280–288. doi: 10.1093/aje/kwm075
   PubMed Web of Science ®Google Scholar
• Apostolou S, Klein JO, Mitsuuchi Y, Shetler JN, Poulikakos PI, Jhanwar SC, Kruger WD, Testa JR. Growth inhibition and induction of apoptosis in mesothelioma cells by selenium and dependence on selenoprotein SEP15 genotype. Oncogene. 2004;23(29):5032–5040. doi: 10.1038/sj.onc.1207683
   PubMed Web of Science ®Google Scholar
• Jablonska E, Gromadzinska J, Peplonska B, Fendler W, Reszka E, Krol MB, Wieczorek E, Bukowska A, Gresner P, Galicki M, et al. Lipid peroxidation and glutathione peroxidase activity relationship in breast cancer depends on functional polymorphism of GPX1. BMC Cancer. 2015;15(1):657. doi: 10.1186/s12885-015-1680-4
   PubMed Web of Science ®Google Scholar
• Jablonska E, Gromadzinska J, Sobala W, Reszka E, Wasowicz W. Lung cancer risk associated with selenium status is modified in smoking individuals by Sep15 polymorphism. Eur J Nutr. 2008;47(1):47–54. doi: 10.1007/s00394-008-0696-9
   PubMed Web of Science ®Google Scholar
• Jaworska K, Gupta S, Durda K, Muszyńska M, Sukiennicki G, Jaworowska E, Grodzki T, Sulikowski M, Woloszczyk P, Wójcik J, et al. A low selenium level is associated with lung and laryngeal cancers. PLoS One. 2013;8(3):e59051. doi: 10.1371/journal.pone.0059051
   PubMed Web of Science ®Google Scholar
• Karunasinghe N, Han DY, Goudie M, Zhu S, Bishop K, Wang A, Duan H, Lange K, Ko S, Medhora R, et al. Prostate disease risk factors among a New Zealand cohort. J Nutrigenet Nutrigenomics. 2012;5(6):339–351. doi: 10.1159/000346279
   PubMedGoogle Scholar
• Meplan C, Hughes DJ, Pardini B, Naccarati A, Soucek P, Vodickova L, Hlavata I, Vrana D, Vodicka P, Hesketh JE, et al. Genetic variants in selenoprotein genes increase risk of colorectal cancer. Carcinogenesis. 2010;31(6):1074–1079. doi: 10.1093/carcin/bgq076
   PubMed Web of Science ®Google Scholar
• Mohammaddoust S, Salehi Z, Saeidi Saedi H. SEPP1 and SEP15 gene polymorphisms and susceptibility to breast cancer. Br J Biomed Sci. 2018;75(1):36–39. doi: 10.1080/09674845.2017.1333241
   Web of Science ®Google Scholar
• Pellatt AJ, Wolff RK, John EM, Torres-Mejia G, Hines LM, Baumgartner KB, Giuliano AR, Lundgreen A, Slattery ML. SEPP1 influences breast cancer risk among women with greater native American ancestry: the breast cancer health disparities study. PLoS One. 2013;8(11):e80554. doi: 10.1371/journal.pone.0080554
   PubMed Web of Science ®Google Scholar
• Penney KL, Schumacher FR, Li H, Kraft P, Morris JS, Kurth T, Mucci LA, Hunter DJ, Kantoff PW, Stampfer MJ, et al. A large prospective study of SEP15 genetic variation, interaction with plasma selenium levels, and prostate cancer risk and survival. Cancer Prev Res (Phila). 2010;3(5):604–610. doi: 10.1158/1940-6207.CAPR-09-0216
   PubMed Web of Science ®Google Scholar
• Reszka E, Gromadzinska J, Jablonska E, Wasowicz W, Jablonowski Z, Sosnowski M. Level of selenoprotein transcripts in peripheral leukocytes of patients with bladder cancer and healthy individuals. Clin Chem Lab Med. 2009;47(9):1125–1132. doi: 10.1515/CCLM.2009.261
   PubMed Web of Science ®Google Scholar
• Steinbrecher A, Meplan C, Hesketh J, Schomburg L, Endermann T, Jansen E, Akesson B, Rohrmann S, Linseisen J. Effects of selenium status and polymorphisms in selenoprotein genes on prostate cancer risk in a prospective study of European men. Cancer Epidemiol Biomarkers Prev. 2010;19(11):2958–2968. doi: 10.1158/1055-9965.EPI-10-0364
   PubMed Web of Science ®Google Scholar
• Sutherland A, Kim DH, Relton C, Ahn YO, Hesketh J. Polymorphisms in the selenoprotein S and 15-kDa selenoprotein genes are associated with altered susceptibility to colorectal cancer. Genes Nutr. 2010;5(3):215–223. doi: 10.1007/s12263-010-0176-8
   PubMed Web of Science ®Google Scholar
• Watrowski R, Castillo-Tong DC, Fabjani G, Schuster E, Fischer M, Zeillinger R. The 811 C/T polymorphism in the 3' untranslated region of the selenoprotein 15-kDa (Sep15) gene and breast cancer in Caucasian women. Tumor Biol. 2016;37(1):1009–1015. doi: 10.1007/s13277-015-3847-7
   PubMedGoogle Scholar
• Wells GS, Shea B, O’Connell D, Peterson J, Welch V, Losos M ,Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of case-control studies in meta-analyses. Ottawa Health Research Institute (Ottawa, Canada) 2011; 2011.
   Google Scholar
• Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–560.
   PubMed Web of Science ®Google Scholar
• Chen H, Cohen P, Chen S. How big is a big odds ratio? Interpreting the magnitudes of odds ratios in epidemiological studies. Commun Stat—Simul C. 2010;39(4):860–864.
   Web of Science ®Google Scholar
• Goodman SN. Toward evidence-based medical statistics. 2: The Bayes factor. Ann Intern Med. 1999;130(12):1005–1013.
   PubMed Web of Science ®Google Scholar
• Royall R. Statistical evidence: the likelihood paradigm. London (UK): Chapman and Hall; 1997.
   Google Scholar
• Goodman SN. Introduction to Bayesian methods I: measuring the strength of evidence. Clin Trials. 2005;2(4):282–290. Discussion 301-4, 364-78, doi: 10.1191/1740774505cn098oa
   PubMed Web of Science ®Google Scholar
• Poole C. Low P-values or narrow confidence intervals: which are more durable? Epidemiology. 2001;12(3):291–294.
   PubMed Web of Science ®Google Scholar
• Pabalan N, Sukcharoensin S, Butthongkomvong K, Jarjanazi H, Thitapakorn V. Expression and serum levels of mucin 5AC (MUC5AC) as a biomarker for cholangiocarcinoma: a meta-analysis. J Gastrointest Canc. 2019;50(1):54–61. doi: 10.1007/s12029-017-0032-9
   PubMed Web of Science ®Google Scholar
• Higgins JP. Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol. 2008;37(5):1158–1160. doi: 10.1093/ije/dyn204
   PubMed Web of Science ®Google Scholar
• Lau J, Ioannidis JP, Schmid CH. Quantitative synthesis in systematic reviews. Ann Intern Med. 1997;127(9):820–826.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–1558.
   PubMed Web of Science ®Google Scholar
• Galbraith RF. A note on graphical presentation of estimated odds ratios from several clinical trials. Stat Med. 1988;7(8):889–894.
   PubMed Web of Science ®Google Scholar
• Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22(4):719–748.
   PubMed Web of Science ®Google Scholar
• Nikolakopoulou A, Mavridis D, Salanti G. Demystifying fixed and random effects meta-analysis. Evid Based Mental Health. 2014;17(2):53–57. doi: 10.1136/eb-2014-101795
   PubMedGoogle Scholar
• Sedgwick P. Meta-analyses: what is heterogeneity? BMJ. 2015;350(mar16 1):h1435. doi: 10.1136/bmj.h1435
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177–188.
   PubMedGoogle Scholar
• Ioannidis JP, Trikalinos TA. The appropriateness of asymmetry tests for publication bias in meta-analyses: a large survey. CMAJ. 2007;176(8):1091–1096. doi: 10.1503/cmaj.060410
   PubMed Web of Science ®Google Scholar
• Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–634.
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50(4):1088–1101.
   PubMed Web of Science ®Google Scholar
• Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4:1. doi: 10.1186/2046-4053-4-1
   Google Scholar
• Goodman S and Greenland S Assessing the unreliability of the medical literature: a response to “why most published research findings are false”. Department of Biostatistics, Johns Hopkins University; The Berkeley Electronic Press (bepress) University of California, Los Angeles. 2007.
   Google Scholar
• McNeely ML, Warren S. Value of confidence intervals in determining clinical significance. Physiother Can. 2006;58(3):205–211. doi: 2310/6640.2006.00040
   Google Scholar
• Sutton A, Abrams KR, Jones DR, Sheldon TA, Song F. Methods for meta-analysis in medical research. Chichester: John Wiley & Sons, Ltd; 2000.
   Google Scholar
• Chen Q-C, Ding X-L, Zhu S-F, Su L, Cai D-M, Chen L, He W. Common SEP15 polymorphisms and susceptibility to cancer: a systematic review and meta-analysis. Transl Cancer Res. 2017;6(5):886–893.
   Web of Science ®Google Scholar
• Cooper ML, Adami H-O, Gronberg H, Wiklund F, Green FR, Rayman MP. Interaction between single nucleotide polymorphisms in selenoprotein P and mitochondrial superoxide dismutase determines prostate cancer risk. Cancer Res. 2008;68(24):10171–10177. doi: 10.1158/0008-5472.CAN-08-1827
   PubMed Web of Science ®Google Scholar
• Diwadkar-Navsariwala V, Diamond AM. The link between selenium and chemoprevention: a case for selenoproteins. J Nutr. 2004;134(11):2899–2902.
   PubMed Web of Science ®Google Scholar
• Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J. A method for meta-analysis of molecular association studies. Stat Med. 2005;24(9):1291–1306.
   PubMed Web of Science ®Google Scholar